Posts Tagged ‘erenumab’
Targeting the CGRP System: A New Treatment Option for Medication Overuse Headache
A recent phase 4 trial shows that erenumab, an anti-CGRP receptor antibody, led to MOH remission in patients with chronic migraine and MOH.
Read More